✦ LIBER ✦

Proton Beam Irradiation for Neovascular Age-Related Macular Degeneration

✍ Scribed by Hadi J. Zambarakji; Anne Marie Lane; Eric Ezra; Danny Gauthier; Michael Goitein; Judy A. Adams; John E. Munzenrider; Joan W. Miller; Evangelos S. Gragoudas

Book ID: 116804096
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 559 KB
Volume: 113
Category: Article
ISSN: 0161-6420
DOI: 10.1016/j.ophtha.2006.05.036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

47 Phase I/II study of proton beam irrad

47 Phase I/II study of proton beam irradiation for the treatment of subfoveal choroidal neovascularization TN age related macular degeneration: Treatment techniques and preliminary results

✍ Les T. Yonemoto; Jerry D. Slater; Lilia N. Loredo; Eric J. Friedrichsen; Jeff J. 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 90 KB

Neovascular Age-Related Macular Degenera

Neovascular Age-Related Macular Degeneration

✍ Veritti, Daniele; Sarao, Valentina; Lanzetta, Paolo 📂 Article 📅 2012 🏛 S. Karger AG 🌐 English ⚖ 187 KB

Neovascular Age-Related Macular Degenera

Neovascular Age-Related Macular Degeneration

✍ Aimee V. Chappelow, Dr Peter K. Kaiser 📂 Article 📅 2008 🏛 Springer International Publishing AG 🌐 English ⚖ 150 KB

Neovascular Age-Related Macular Degenera

Neovascular Age-Related Macular Degeneration

✍ Heier, Jeffrey S. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Ranibizumab for Neovascular Age-Related

Ranibizumab for Neovascular Age-Related Macular Degeneration

✍ Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaise 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 299 KB

Ranibizumab for Neovascular Age-Related

Ranibizumab for Neovascular Age-Related Macular Degeneration

✍ Rosenfeld, Philip J.; Brown, David M.; Heier, Jeffrey S.; Boyer, David S.; Kaise 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 299 KB

## Background: Ranibizumab--a recombinant, humanized, monoclonal antibody fab that neutralizes all active forms of vascular endothelial growth factor a--has been evaluated for the treatment of neovascular age-related macular degeneration. ## Methods: In this multicenter, 2-year, double-blind, sha